A novel L1CAM isoform with angiogenic activity generated by NOVA2-mediated alternative splicing.


Journal

eLife
ISSN: 2050-084X
Titre abrégé: Elife
Pays: England
ID NLM: 101579614

Informations de publication

Date de publication:
04 03 2019
Historique:
received: 12 12 2018
accepted: 08 02 2019
entrez: 5 3 2019
pubmed: 5 3 2019
medline: 20 3 2020
Statut: epublish

Résumé

The biological players involved in angiogenesis are only partially defined. Here, we report that endothelial cells (ECs) express a novel isoform of the cell-surface adhesion molecule L1CAM, termed L1-ΔTM. The splicing factor NOVA2, which binds directly to

Identifiants

pubmed: 30829570
doi: 10.7554/eLife.44305
pii: 44305
pmc: PMC6398979
doi:
pii:

Substances chimiques

Angiogenic Proteins 0
L1CAM protein, human 0
NOVA2 protein, human 0
Nerve Tissue Proteins 0
Neural Cell Adhesion Molecule L1 0
Neuro-Oncological Ventral Antigen 0
Protein Isoforms 0
RNA-Binding Proteins 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Associazione Italiana per la Ricerca sul Cancro
ID : IG-17395
Pays : International
Organisme : Worldwide Cancer Research
ID : AICR 10-0091
Pays : United Kingdom
Organisme : Horizon 2020 Framework Programme
ID : ERC-StG-LS2-637591
Pays : International
Organisme : Ministerio de Economía y Competitividad
ID : BFU2017-89201-P
Pays : International
Organisme : Associazione Italiana per la Ricerca sul Cancro
ID : IG-14622
Pays : International
Organisme : Associazione Italiana per la Ricerca sul Cancro
ID : IG-18853
Pays : International
Organisme : Associazione Italiana per la Ricerca sul Cancro
ID : IG-18683
Pays : International

Informations de copyright

© 2019, Angiolini et al.

Déclaration de conflit d'intérêts

EB, MG, MC, FF, PP, ML, CB, DP, AD, CG, GJ, CL, GB, SF, MM, MI, CG, RG, DN, DG No competing interests declared, JM, JS Affiliated with Gene Tools, LLC. Funding bodies had no role in the design of the study and collection, analysis, and interpretation of data and in writing the manuscript. ED Reviewing editor, eLife, CG Consultant for Gene-Tools, LLC. Funding bodies had no role in the design of the study and collection, analysis, and interpretation of data and in writing the manuscript.

Références

Nature. 2008 Nov 27;456(7221):464-9
pubmed: 18978773
J Cell Biol. 2002 Jun 24;157(7):1223-32
pubmed: 12082080
Nat Cell Biol. 2008 Aug;10(8):923-34
pubmed: 18604199
RNA. 2016 Sep;22(9):1285-301
pubmed: 27530828
Proc Natl Acad Sci U S A. 2002 Oct 15;99(21):13413-8
pubmed: 12370422
J Exp Med. 1998 Jun 15;187(12):1953-63
pubmed: 9625755
Stem Cells. 2017 May;35(5):1328-1340
pubmed: 28090691
Cell Rep. 2014 May 22;7(4):1211-26
pubmed: 24813895
Elife. 2016 May 25;5:
pubmed: 27223328
J Cell Biol. 2001 Nov 12;155(4):661-73
pubmed: 11706054
Nat Genet. 2008 Dec;40(12):1413-5
pubmed: 18978789
Proteomics. 2004 Apr;4(4):995-1006
pubmed: 15048981
Science. 2015 Jan 23;347(6220):1260419
pubmed: 25613900
Semin Cell Dev Biol. 2014 Aug;32:30-6
pubmed: 24657195
Mol Cancer. 2017 Jan 30;16(1):8
pubmed: 28137272
PLoS Genet. 2017 Mar 6;13(3):e1006589
pubmed: 28263985
Blood. 2012 Mar 1;119(9):2159-70
pubmed: 22246030
Clin Exp Metastasis. 2013 Apr;30(4):507-20
pubmed: 23212305
Nat Rev Mol Cell Biol. 2017 Jul;18(7):437-451
pubmed: 28488700
Nat Rev Drug Discov. 2011 Jun;10(6):417-27
pubmed: 21629292
Cancer Res. 2008 Feb 15;68(4):1110-8
pubmed: 18281486
Genet Epigenet. 2015 Dec 02;7:19-32
pubmed: 26692764
FEBS Lett. 2003 Dec 18;555(3):572-8
pubmed: 14675776
Cell Adh Migr. 2012 Jul-Aug;6(4):374-84
pubmed: 22796939
Science. 2010 Jul 23;329(5990):439-43
pubmed: 20558669
Science. 2003 Nov 14;302(5648):1212-5
pubmed: 14615540
Nucleic Acids Res. 2010 Aug;38(14):4740-54
pubmed: 20385588
Mol Cell Biol. 2005 Oct;25(20):9040-53
pubmed: 16199880
J Neurosci. 2000 Aug 1;20(15):5696-702
pubmed: 10908608
Nature. 2006 Nov 30;444(7119):580-6
pubmed: 17065982
Med Biol. 1986;64(6):345-9
pubmed: 3821197
Nucleic Acids Res. 2010 Jul;38(Web Server issue):W281-5
pubmed: 20501600
Front Biosci. 2003 Sep 01;8:s1210-25
pubmed: 12957823
Cell Rep. 2015 Jun 9;11(9):1377-84
pubmed: 26004184
Elife. 2016 May 25;5:
pubmed: 27223325
J Clin Invest. 2014 Oct;124(10):4335-50
pubmed: 25157817
Mol Biol Cell. 2002 Apr;13(4):1175-89
pubmed: 11950930
Proc Natl Acad Sci U S A. 2000 May 23;97(11):5740-5
pubmed: 10811881
Cell Mol Life Sci. 2010 Jul;67(14):2425-37
pubmed: 20237819
Onco Targets Ther. 2018 Sep 20;11:6049-6056
pubmed: 30275709
J Cell Biol. 2003 May 26;161(4):793-804
pubmed: 12771128
Nucleic Acids Res. 2013 Oct;41(18):8665-79
pubmed: 23863836
Mol Cell Neurosci. 2008 Mar;37(3):528-36
pubmed: 18222703
J Neurochem. 2000 Oct;75(4):1520-7
pubmed: 10987832
Nature. 2008 Nov 27;456(7221):470-6
pubmed: 18978772
Expert Opin Ther Targets. 2015;19(10):1361-77
pubmed: 26125971
Curr Opin Genet Dev. 2018 Feb;48:67-74
pubmed: 29136527
Neuron. 2010 Jun 24;66(6):848-58
pubmed: 20620871
Oncotarget. 2015 Sep 29;6(29):28389-400
pubmed: 26318044
Proc Natl Acad Sci U S A. 2005 Dec 27;102(52):18920-5
pubmed: 16354838
J Mol Med (Berl). 2009 Jan;87(1):99-112
pubmed: 18931829
Nature. 2010 Jan 28;463(7280):457-63
pubmed: 20110989
Neuron. 1994 Sep;13(3):583-94
pubmed: 7917292
Pharmacol Res. 2016 May;107:172-185
pubmed: 27013279
Nat Commun. 2015 Oct 08;6:8479
pubmed: 26446569
Clin Cancer Res. 2011 Oct 15;17(20):6406-16
pubmed: 22003068
Oncogene. 2014 Nov 13;33(46):5311-8
pubmed: 24336324
Nat Rev Genet. 2014 Oct;15(10):689-701
pubmed: 25112293
Genome Res. 2017 Oct;27(10):1759-1768
pubmed: 28855263
Dev Cell. 2009 Feb;16(2):222-31
pubmed: 19217424
Nat Rev Cancer. 2005 Jun;5(6):436-46
pubmed: 15928674
Mol Cell. 2011 Aug 5;43(3):353-68
pubmed: 21816343
Cold Spring Harb Symp Quant Biol. 2006;71:321-7
pubmed: 17381312
Mech Ageing Dev. 2013 Sep;134(9):356-66
pubmed: 23747814
Expert Rev Anticancer Ther. 2016;16(3):359-71
pubmed: 26781307
J Exp Med. 2009 Mar 16;206(3):623-35
pubmed: 19273627
Trends Mol Med. 2002 Oct;8(10):483-9
pubmed: 12383771
J Cell Sci. 2005 Feb 1;118(Pt 3):623-32
pubmed: 15657074
J Neurosci Res. 1997 Mar 15;47(6):655-65
pubmed: 9089215
Int J Cell Biol. 2013;2013:962038
pubmed: 24285959
Mod Pathol. 2006 Mar;19(3):399-406
pubmed: 16400320
Genome Biol. 2009;10(3):R30
pubmed: 19296853
Anal Biochem. 2000 Sep 10;284(2):316-26
pubmed: 10964415
J Neurochem. 2012 Mar;120(5):699-709
pubmed: 22176577
Nat Rev Mol Cell Biol. 2009 Nov;10(11):741-54
pubmed: 19773805
Stem Cells. 2011 Dec;29(12):2094-9
pubmed: 21957033
Methods Mol Biol. 2015;1214:41-7
pubmed: 25468598
Nat Neurosci. 2007 Jan;10(1):19-26
pubmed: 17189949
Fluids Barriers CNS. 2013 Mar 26;10(1):16
pubmed: 23531482
J Neurosci. 1993 Nov;13(11):4764-75
pubmed: 8229197

Auteurs

Francesca Angiolini (F)

Unit of Gynecological Oncology Research, Program of Gynecological Oncology, IEO, European Institute of Oncology IRCCS, Milan, Italy.

Elisa Belloni (E)

Istituto di Genetica Molecolare, Consiglio Nazionale delle Ricerche, Pavia, Italy.

Marco Giordano (M)

Unit of Gynecological Oncology Research, Program of Gynecological Oncology, IEO, European Institute of Oncology IRCCS, Milan, Italy.

Matteo Campioni (M)

The Armenise-Harvard Laboratory of Structural Biology, Department of Biology and Biotechnology, University of Pavia, Pavia, Italy.

Federico Forneris (F)

The Armenise-Harvard Laboratory of Structural Biology, Department of Biology and Biotechnology, University of Pavia, Pavia, Italy.

Maria Paola Paronetto (MP)

Department of Movement, Human and Health Sciences, Università degli Studi di Roma "Foro Italico", Rome, Italy.

Michela Lupia (M)

Unit of Gynecological Oncology Research, Program of Gynecological Oncology, IEO, European Institute of Oncology IRCCS, Milan, Italy.

Chiara Brandas (C)

Istituto di Genetica Molecolare, Consiglio Nazionale delle Ricerche, Pavia, Italy.

Davide Pradella (D)

Istituto di Genetica Molecolare, Consiglio Nazionale delle Ricerche, Pavia, Italy.
Università degli Studi di Pavia, Pavia, Italy.

Anna Di Matteo (A)

Istituto di Genetica Molecolare, Consiglio Nazionale delle Ricerche, Pavia, Italy.

Costanza Giampietro (C)

FIRC Institute of Molecular Oncology, Milan, Italy.

Giovanna Jodice (G)

Molecular Medicine Program, IEO, European Institute of Oncology IRCCS, Milan, Italy.

Chiara Luise (C)

Molecular Medicine Program, IEO, European Institute of Oncology IRCCS, Milan, Italy.

Giovanni Bertalot (G)

Molecular Medicine Program, IEO, European Institute of Oncology IRCCS, Milan, Italy.

Stefano Freddi (S)

Molecular Medicine Program, IEO, European Institute of Oncology IRCCS, Milan, Italy.

Matteo Malinverno (M)

FIRC Institute of Molecular Oncology, Milan, Italy.

Manuel Irimia (M)

Centre for Genomic Regulation, The Barcelona Institute of Science and Technology, Barcelona, Spain.
Universitat Pompeu Fabra, Barcelona, Spain.
Institució Catalana de Recerca i Estudis Avançats, Barcelona, Spain.

Jon D Moulton (JD)

Gene Tools LLC, Philomath, United States.

James Summerton (J)

Gene Tools LLC, Philomath, United States.

Antonella Chiapparino (A)

The Armenise-Harvard Laboratory of Structural Biology, Department of Biology and Biotechnology, University of Pavia, Pavia, Italy.

Carmen Ghilardi (C)

Laboratory of Biology and Treatment of Metastasis, IRCCS-Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy.

Raffaella Giavazzi (R)

Laboratory of Biology and Treatment of Metastasis, IRCCS-Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy.

Daniel Nyqvist (D)

Division of Vascular Biology, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden.

Davide Gabellini (D)

Division of Genetics and Cell Biology, IRCCS San Raffaele Scientific Institute, Milan, Italy.

Elisabetta Dejana (E)

FIRC Institute of Molecular Oncology, Milan, Italy.
Rudbeck Laboratory and Science for Life Laboratory, Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.

Ugo Cavallaro (U)

Unit of Gynecological Oncology Research, Program of Gynecological Oncology, IEO, European Institute of Oncology IRCCS, Milan, Italy.

Claudia Ghigna (C)

Istituto di Genetica Molecolare, Consiglio Nazionale delle Ricerche, Pavia, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH